Source: Press Release India

Press Release: PMC Group : PMC Biogenix Announces Price Increase on Armoslip and Kemamide Fatty Amides

Business Wire India PMC Biogenix Inc. announces that effective June 1, 2021 or as contracts permit, prices for Armoslip and Kemamide brand primary and secondary fatty amides and bisamides will increase by $1.00 to...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Paritosh M. Chakrabarti's photo - CEO of PMC Group

CEO

Paritosh M. Chakrabarti

CEO Approval Rating

90/100

Read more